Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Reports from the same study

Selected source-checked relationships. Keep these records separate, but do not count each report as an independent study or add their participant totals.

Johns Hopkins MDD waiting-list trial

The primary report and 12-month follow-up describe the same trial cohort. Follow-up does not provide a new randomized comparison. Checked 2026-11-03.

Registry identity: NCT03181529.

Coverage is incomplete. Missing links do not establish independence. Relationship data and source evidence (JSON).

Read this study in context

This report is included in a selected evidence comparison. Review its population, primary endpoint, findings and limitations alongside the other selected reports.

These original educational annotations are not an exhaustive systematic review or a clinical guideline.

Bibliographic context

Journal
JAMA psychiatry
Date
2021-05-01
Source
PubMed
DOI
10.1001/jamapsychiatry.2020.3285
PubMed
33146667
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:54:14 UTC
Metadata last checked
2026-08-09 08:28:22 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients2026-11-10Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression2026-11-01High-Quality Genome Assembly and Transcriptomic Analysis Reveal Potential Pathways for Psilocybin Biosynthesis in Gymnopilus dilepis2026-10-28Clinical Evidence on Psilocybin and Its Representation in Media Reporting2026-10-20From Altered States to Fundamental Peace: Taxonomies of Consciousness, Psychedelics and Hypnosis Through the Lens of the Yoga Vāsiṣṭha2026-10-18Psychedelics in neurosurgery: Potential utility in prevention, perioperative care, pain management, and neurorehabilitation2026-10-09Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysis2026-10-08Study participant perceptions of the relevance of therapist and study team personal psychedelic experience2026-10-03HORMONAL MODULATION OF PSILOCYBIN RESPONSIVITY ACROSS THE FEMALE REPRODUCTIVE LIFESPAN2026-08-31PSYCHEDELICS IN THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND DEPRESSION: A REVIEW OF CLINICAL TRIALS2026-08-31Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy2026-08-13Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)2026-08-12Cardiovascular safety of psilocybin in psychiatric practice: a narrative review2026-08-01Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis2026-08-01The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis2026-08-01Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial2026-07-30Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder2026-07-16Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-13Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study2026-07-01Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits2026-07-01

Related papers